AAAAAA

   
Results: 1-12 |
Results: 12
p16/p14(ARF) cell cycle regulatory pathways in primary neuroblastoma: p16 expression is associated with advanced stage disease
Authors: Omura-Minamisawa, M Diccianni, MB Chang, RC Batova, A Bridgeman, LJ Schiff, J Cohn, SL London, WB Yu, AL
Citation: M. Omura-minamisawa et al., p16/p14(ARF) cell cycle regulatory pathways in primary neuroblastoma: p16 expression is associated with advanced stage disease, CLIN CANC R, 7(11), 2001, pp. 3481-3490
Expression and localization of the CDC34 ubiquitin-conjugating enzyme in pediatric acute lymphoblastic leukemia
Authors: Eliseeva, E Pati, D Diccinanni, MB Yu, AL Mohsin, SK Margolin, JF Plon, SE
Citation: E. Eliseeva et al., Expression and localization of the CDC34 ubiquitin-conjugating enzyme in pediatric acute lymphoblastic leukemia, CELL GROWTH, 12(8), 2001, pp. 427-433
Thioredoxin expression in primary T-cell acute lymphoblastic leukemia and its therapeutic implication
Authors: Shao, LE Diccianni, MB Tanaka, T Gribi, R Yu, AL Pullen, JD Camitta, BM Yu, J
Citation: Le. Shao et al., Thioredoxin expression in primary T-cell acute lymphoblastic leukemia and its therapeutic implication, CANCER RES, 61(19), 2001, pp. 7333-7338
Preconditioning with fetal cord blood facilitates engraftment of primary childhood T-cell acute lymphoblastic leukemia in immunodeficient mice
Authors: Dialynas, DP Lee, MJ Gold, DP Shao, LE Yu, AL Borowitz, MJ Yu, J
Citation: Dp. Dialynas et al., Preconditioning with fetal cord blood facilitates engraftment of primary childhood T-cell acute lymphoblastic leukemia in immunodeficient mice, BLOOD, 97(10), 2001, pp. 3218-3225
Ras activation in normal white blood cells and childhood acute lymphoblastic leukemia
Authors: von Lintig, FC Huvar, I Law, P Diccianni, MB Yu, AL Boss, GR
Citation: Fc. Von Lintig et al., Ras activation in normal white blood cells and childhood acute lymphoblastic leukemia, CLIN CANC R, 6(5), 2000, pp. 1804-1810
Universal inactivation of both p16 and p15 but not downstream components is an essential event in the pathogenesis of T-cell acute lymphoblastic leukemia
Authors: Omura-Minamisawa, M Diccianni, MB Batova, A Chang, RC Bridgeman, LJ Yu, J Pullen, J Bowman, WP Yu, AL
Citation: M. Omura-minamisawa et al., Universal inactivation of both p16 and p15 but not downstream components is an essential event in the pathogenesis of T-cell acute lymphoblastic leukemia, CLIN CANC R, 6(4), 2000, pp. 1219-1228
Human cord blood conditioned medium enhances leukemia colony formation in vitro
Authors: Shao, L Dialynas, DP Yu, AL Mackintosh, E Yu, J
Citation: L. Shao et al., Human cord blood conditioned medium enhances leukemia colony formation in vitro, LEUK RES, 24(12), 2000, pp. 1041-1048
In vitro sensitivity of T-cell lymphoblastic leukemia to UCN-01 (7-hydroxystaurosporine) is dependent on p16 protein status: A pediatric oncology group study
Authors: Omura-Minamisawa, M Diccianni, MB Batova, A Chang, RC Bridgeman, LJ Yu, J de Wit, E Kung, FH Pullen, JD Yu, AL
Citation: M. Omura-minamisawa et al., In vitro sensitivity of T-cell lymphoblastic leukemia to UCN-01 (7-hydroxystaurosporine) is dependent on p16 protein status: A pediatric oncology group study, CANCER RES, 60(23), 2000, pp. 6573-6576
Immunotherapy of neuroblastoma
Authors: Cheung, NKV Yu, AL
Citation: Nkv. Cheung et Al. Yu, Immunotherapy of neuroblastoma, NEUROBLASTOMA, 2000, pp. 541-549
The Ch14.18-GM-CSF fusion protein is effective at mediating antibody-dependent cellular cytotoxicity and complement-dependent cytotoxicity in vitro
Authors: Batova, A Kamps, A Gillies, SD Reisfeld, RA Yu, AL
Citation: A. Batova et al., The Ch14.18-GM-CSF fusion protein is effective at mediating antibody-dependent cellular cytotoxicity and complement-dependent cytotoxicity in vitro, CLIN CANC R, 5(12), 1999, pp. 4259-4263
Methylation of p16(INK4A) in primary gynecologic malignancy
Authors: Wong, YF Chung, TKH Cheung, TH Nobori, T Yu, AL Yu, J Batova, A Lai, KWH Chang, AMZ
Citation: Yf. Wong et al., Methylation of p16(INK4A) in primary gynecologic malignancy, CANCER LETT, 136(2), 1999, pp. 231-235
Use of alanosine as a methylthioadenosine phosphorylase-selective therapy for T-cell acute lymphoblastic leukemia in vitro
Authors: Batova, A Diccianni, MB Omura-Minamisawa, M Yu, J Carrera, CJ Bridgeman, LJ Kung, FH Pullen, J Amylon, MD Yu, AL
Citation: A. Batova et al., Use of alanosine as a methylthioadenosine phosphorylase-selective therapy for T-cell acute lymphoblastic leukemia in vitro, CANCER RES, 59(7), 1999, pp. 1492-1497
Risultati: 1-12 |